Skip to main content

Patient Selection and Guidelines for Resection and Liver-Directed Therapies: Non-colorectal, Non-neuroendocrine Liver Metastases

  • Chapter
  • First Online:
Primary and Metastatic Liver Tumors

Abstract

Liver resection for colorectal and neuroendocrine hepatic metastases has traditionally been associated with favorable results in well-selected patients. However, the role of hepatic resection and other liver-directed therapies for non-colorectal, non-neuroendocrine liver metastases has been less adequately described. In this chapter, we review the current literature on surgical and other locoregional treatment strategies for non-colorectal, non-neuroendocrine liver metastases, focusing on prognostic factors, survival outcomes, and selection criteria based on the specific histology of the primary tumor, including breast cancer, genitourinary tract cancer, non-colorectal gastrointestinal tract cancer, and melanoma.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Malik HZ, Prasad KR, Halazun KJ, et al. Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg. 2007;246:806–14.

    Article  Google Scholar 

  2. Quan D, Gallinger S, Nhan C, et al. The role of liver resection for colorectal cancer metastases in an era of multimodality treatment: a systematic review. Surgery. 2012;151:860–70.

    Article  Google Scholar 

  3. Simmonds PC, Primrose JN, Colquitt JL, et al. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94:982–99.

    Article  CAS  Google Scholar 

  4. Mayo SC, de Jong MC, Pulitano C, et al. Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. Ann Surg Oncol. 2010;17:3129–36.

    Article  Google Scholar 

  5. Mayo SC, de Jong MC, Bloomston M, et al. Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. Ann Surg Oncol. 2011;18:3657–65.

    Article  Google Scholar 

  6. Groeschl RT, Nachmany I, Steel JL, et al. Hepatectomy for noncolorectal non-neuroendocrine metastatic cancer: a multi-institutional analysis. J Am Coll Surg. 2012;214:769–77.

    Article  Google Scholar 

  7. Cordera F, Rea DJ, Rodriguez-Davalos M, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases. J Gastrointest Surg. 2005;9:1361–70.

    Article  Google Scholar 

  8. Adam R, Chiche L, Aloia T, et al. Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg. 2006;244:524–35.

    Article  Google Scholar 

  9. Abood G, Bowen M, Potkul R, et al. Hepatic resection for recurrent metastatic ovarian cancer. Am J Surg. 2008;195:370–3; discussion 373.

    Article  Google Scholar 

  10. Bosquet JG, Merideth MA, Podratz KC, et al. Hepatic resection for metachronous metastases from ovarian carcinoma. HPB (Oxford). 2006;8:93–6.

    Article  Google Scholar 

  11. Merideth MA, Cliby WA, Keeney GL, et al. Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol. 2003;89:16–21.

    Article  Google Scholar 

  12. Elias D, Cavalcanti de Albuquerque A, Eggenspieler P, et al. Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg. 1998;187:487–93.

    Article  CAS  Google Scholar 

  13. Ruys AT, Tanis PJ, Nagtegaal ID, et al. Surgical treatment of renal cell cancer liver metastases: a population-based study. Ann Surg Oncol. 2011;18:1932–8.

    Article  Google Scholar 

  14. Goulet RJ Jr, Hardacre JM, Einhorn LH, et al. Hepatic resection for disseminated germ cell carcinoma. Ann Surg. 1990;212:290–3; discussion 293–4.

    Article  Google Scholar 

  15. Roh HJ, Kim DY, Joo WD, et al. Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch Gynecol Obstet. 2011;284:1223–9.

    Article  Google Scholar 

  16. Alves A, Adam R, Majno P, et al. Hepatic resection for metastatic renal tumors: is it worthwhile? Ann Surg Oncol. 2003;10:705–10.

    Article  CAS  Google Scholar 

  17. Weitz J, Blumgart LH, Fong Y, et al. Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg. 2005;241:269–76.

    Article  Google Scholar 

  18. Stief CG, Jahne J, Hagemann JH, et al. Surgery for metachronous solitary liver metastases of renal cell carcinoma. J Urol. 1997;158:375–7.

    Article  CAS  Google Scholar 

  19. Staehler MD, Kruse J, Haseke N, et al. Liver resection for metastatic disease prolongs survival in renal cell carcinoma: 12-year results from a retrospective comparative analysis. World J Urol. 2010;28:543–7.

    Article  Google Scholar 

  20. Langan RC, Ripley RT, Davis JL, et al. Liver directed therapy for renal cell carcinoma. J Cancer. 2012;3:184–90.

    Article  Google Scholar 

  21. You YN, Leibovitch BC, Que FG. Hepatic metastasectomy for testicular germ cell tumors: is it worth it? J Gastrointest Surg. 2009;13:595–601.

    Article  Google Scholar 

  22. Motzer RJ, Mazumdar M, Bacik J, et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol. 1999;17:2530–40.

    Article  CAS  Google Scholar 

  23. Temkin SM, Fleming G. Current treatment of metastatic endometrial cancer. Cancer Control. 2009;16:38–45.

    Article  Google Scholar 

  24. Adam R, Aloia T, Krissat J, et al. Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg. 2006;244:897–907; discussion 907–8.

    Article  Google Scholar 

  25. Pocard M, Pouillart P, Asselain B, et al. Hepatic resection in metastatic breast cancer: results and prognostic factors. Eur J Surg Oncol. 2000;26:155–9.

    Article  CAS  Google Scholar 

  26. Abbott DE, Brouquet A, Mittendorf EA, et al. Resection of liver metastases from breast cancer: estrogen receptor status and response to chemotherapy before metastasectomy define outcome. Surgery. 2012;151:710–6.

    Article  Google Scholar 

  27. Thelen A, Benckert C, Jonas S, et al. Liver resection for metastases from breast cancer. J Surg Oncol. 2008;97:25–9.

    Article  Google Scholar 

  28. Fitzgerald TL, Brinkley J, Banks S, et al. The benefits of liver resection for non-colorectal, non-neuroendocrine liver metastases: a systematic review. Langenbecks Arch Surg. 2014;399:989–1000.

    Article  Google Scholar 

  29. Mariani P, Servois V, De Rycke Y, et al. Liver metastases from breast cancer: surgical resection or not? A case-matched control study in highly selected patients. Eur J Surg Oncol. 2013;39:1377–83.

    Article  CAS  Google Scholar 

  30. Spolverato G, Vitale A, Bagante F, et al. Liver resection for breast cancer liver metastases: a cost-utility analysis. Ann Surg. 2017;265:792–9.

    Article  Google Scholar 

  31. Sadot E, Lee SY, Sofocleous CT, et al. Hepatic resection or ablation for isolated breast cancer liver metastasis: a case-control study with comparison to medically treated patients. Ann Surg. 2016;264:147–54.

    Article  Google Scholar 

  32. Bresadola V, Rossetto A, Adani GL, et al. Liver resection for noncolorectal and nonneuroendocrine metastases: results of a study on 56 patients at a single institution. Tumori. 2011;97:316–22.

    Article  Google Scholar 

  33. de Jong MC, Tsai S, Cameron JL, et al. Safety and efficacy of curative intent surgery for peri-ampullary liver metastasis. J Surg Oncol. 2010;102:256–63.

    Article  Google Scholar 

  34. Polee MB, Hop WC, Kok TC, et al. Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy. Br J Cancer. 2003;89:2045–50.

    Article  CAS  Google Scholar 

  35. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817–25.

    Article  CAS  Google Scholar 

  36. Slotta JE, Schuld J, Distler S, et al. Hepatic resection of non-colorectal and non-neuroendocrine liver metastases—survival benefit for patients with non-gastrointestinal primary cancers—a case-controlled study. Int J Surg. 2014;12:163–8.

    Article  Google Scholar 

  37. Shima Y, Horimi T, Ishikawa T, et al. Aggressive surgery for liver metastases from gastrointestinal stromal tumors. J Hepatobiliary Pancreat Surg. 2003;10:77–80.

    PubMed  Google Scholar 

  38. DeMatteo RP, Shah A, Fong Y, et al. Results of hepatic resection for sarcoma metastatic to liver. Ann Surg. 2001;234:540–7; discussion 547–8.

    Article  CAS  Google Scholar 

  39. Nunobe S, Sano T, Shimada K, et al. Surgery including liver resection for metastatic gastrointestinal stromal tumors or gastrointestinal leiomyosarcomas. Jpn J Clin Oncol. 2005;35:338–41.

    Article  Google Scholar 

  40. Xia L, Zhang MM, Ji L, et al. Resection combined with imatinib therapy for liver metastases of gastrointestinal stromal tumors. Surg Today. 2010;40:936–42.

    Article  CAS  Google Scholar 

  41. Pawlik TM, Vauthey JN, Abdalla EK, et al. Results of a single-center experience with resection and ablation for sarcoma metastatic to the liver. Arch Surg. 2006;141:537–43; discussion 543–4.

    Article  Google Scholar 

  42. Pawlik TM, Zorzi D, Abdalla EK, et al. Hepatic resection for metastatic melanoma: distinct patterns of recurrence and prognosis for ocular versus cutaneous disease. Ann Surg Oncol. 2006;13:712–20.

    Article  Google Scholar 

  43. Rivoire M, Kodjikian L, Baldo S, et al. Treatment of liver metastases from uveal melanoma. Ann Surg Oncol. 2005;12:422–8.

    Article  Google Scholar 

  44. Mariani P, Piperno-Neumann S, Servois V, et al. Surgical management of liver metastases from uveal melanoma: 16 years’ experience at the Institut Curie. Eur J Surg Oncol. 2009;35:1192–7.

    Article  CAS  Google Scholar 

  45. Earle SA, Perez EA, Gutierrez JC, et al. Hepatectomy enables prolonged survival in select patients with isolated noncolorectal liver metastasis. J Am Coll Surg. 2006;203:436–46.

    Article  Google Scholar 

  46. Berney T, Mentha G, Roth AD, et al. Results of surgical resection of liver metastases from non-colorectal primaries. Br J Surg. 1998;85:1423–7.

    Article  CAS  Google Scholar 

  47. Duan XF, Dong NN, Zhang T, et al. Comparison of surgical outcomes in patients with colorectal liver metastases versus non-colorectal liver metastases: a Chinese experience. Hepatol Res. 2012;42:296–303.

    Article  Google Scholar 

  48. Lindell G, Ohlsson B, Saarela A, et al. Liver resection of noncolorectal secondaries. J Surg Oncol. 1998;69:66–70.

    Article  CAS  Google Scholar 

  49. Treska V, Liska V, Skalicky T, et al. Non-colorectal liver metastases: surgical treatment options. Hepatogastroenterology. 2012;59:245–8.

    PubMed  Google Scholar 

  50. Takada Y, Otsuka M, Seino K, et al. Hepatic resection for metastatic tumors from noncolorectal carcinoma. Hepatogastroenterology. 2001;48:83–6.

    CAS  PubMed  Google Scholar 

  51. Lendoire J, Moro M, Andriani O, et al. Liver resection for non-colorectal, non-neuroendocrine metastases: analysis of a multicenter study from Argentina. HPB (Oxford). 2007;9:435–9.

    Article  CAS  Google Scholar 

  52. Harrison LE, Brennan MF, Newman E, et al. Hepatic resection for noncolorectal, nonneuroendocrine metastases: a fifteen-year experience with ninety-six patients. Surgery. 1997;121:625–32.

    Article  CAS  Google Scholar 

  53. Yedibela S, Gohl J, Graz V, et al. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review. Ann Surg Oncol. 2005;12:778–85.

    Article  Google Scholar 

  54. van Ruth S, Mutsaerts E, Zoetmulder FA, et al. Metastasectomy for liver metastases of non-colorectal primaries. Eur J Surg Oncol. 2001;27:662–7.

    Article  Google Scholar 

  55. Goering JD, Mahvi DM, Niederhuber JE, et al. Cryoablation and liver resection for noncolorectal liver metastases. Am J Surg. 2002;183:384–9.

    Article  Google Scholar 

  56. Verhoef C, Kuiken BW, IJzermans JN, et al. Partial hepatic resection for liver metastases of non-colorectal origin, is it justified? Hepatogastroenterology. 2007;54:1517–21.

    CAS  PubMed  Google Scholar 

  57. Ercolani G, Vetrone G, Grazi GL, et al. The role of liver surgery in the treatment of non-colorectal non-neuroendocrine metastases (NCRNNE). Analysis of 134 resected patients. Minerva Chir. 2009;64:551–8.

    CAS  PubMed  Google Scholar 

  58. Karavias DD, Tepetes K, Karatzas T, et al. Liver resection for metastatic non-colorectal non-neuroendocrine hepatic neoplasms. Eur J Surg Oncol. 2002;28:135–9.

    Article  CAS  Google Scholar 

  59. Takemura N, Saiura A, Koga R, et al. Long-term results of hepatic resection for non-colorectal, non-neuroendocrine liver metastasis. Hepatogastroenterology. 2013;60:1705–12.

    PubMed  Google Scholar 

  60. O’Rourke TR, Tekkis P, Yeung S, et al. Long-term results of liver resection for non-colorectal, non-neuroendocrine metastases. Ann Surg Oncol. 2008;15:207–18.

    Article  Google Scholar 

  61. Marudanayagam R, Sandhu B, Perera MT, et al. Hepatic resection for non-colorectal, non-neuroendocrine, non-sarcoma metastasis: a single-centre experience. HPB (Oxford). 2011;13:286–92.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to George A. Poultsides .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Fong, Z.V., Poultsides, G.A., Qadan, M. (2018). Patient Selection and Guidelines for Resection and Liver-Directed Therapies: Non-colorectal, Non-neuroendocrine Liver Metastases. In: Cardona, K., Maithel, S. (eds) Primary and Metastatic Liver Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-91977-5_23

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91977-5_23

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91976-8

  • Online ISBN: 978-3-319-91977-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics